RBC Capital analyst Shagun Singh Chadha maintains $Abbott Laboratories (ABT.US)$ with a buy rating, and adjusts the target price from $125 to $130.
According to TipRanks data, the analyst has a success rate of 48.0% and a total average return of 0.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Abbott Laboratories (ABT.US)$'s main analysts recently are as follows:
Initial assessments indicate that Q3 underlying utilization trends were favorable, notwithstanding the usual summer seasonality that often leads to a sequential decline in elective procedures. Furthermore, the general mood among investors towards MedTech stocks is optimistic as the earnings season approaches, with the expectation that there will be an inclination towards stocks with strong performance and those driven by specific catalysts as the year draws to a close.
Abbott is described as a 'large-cap diversified healthcare play.' It is perceived as a dual narrative company with one side presenting an appealing medical technology segment contributing 45% to total global sales of $42B, growing at a rate of 11%-13% annually. The other facet encompasses a non-MedTech division experiencing low- to mid-single-digit growth, affected by litigation concerns on its pediatric nutrition business and a decline in COVID-19 diagnostics sales. With the expectation that these non-MedTech challenges will diminish, Abbott's financial outlook for fiscal 2026 is projected to improve, potentially leading to an increase in sales growth to low-double-digits and a rise in EBIT margins.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.